Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 94748-94749 [2024-28075]
Download as PDF
<![CDATA[
94748
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
TABLE 1—FISCAL YEAR 2024 DISASTER-RECOVERY ADJUSTED FMAP RATES
State
Fiscal year
2023 FMAP
Fiscal year
2024 regular
FMAP
(unadjusted)
Decrease
in FMAP
Disaster-recovery
adjustment *
Disaster-recovery
adjusted
FMAP fiscal
year 2024
Arizona .............................................................
69.56
66.29
3.27
1.64
67.93
* In the first year, the Disaster-Recovery Adjustment is 50 percent of the percentage point decrease between the regular FMAP for such fiscal
year and the FMAP from the preceding fiscal year.
TABLE 2—FISCAL YEAR 2025 DISASTER-RECOVERY ADJUSTED FMAP RATES
State
Fiscal year
2024 FMAP *
Fiscal year
2025 regular
FMAP
(unadjusted)
Decrease
in FMAP
Disaster-recovery
adjustment **
Disaster-recovery
adjusted
FMAP fiscal
year 2025
Arizona .............................................................
67.93
64.89
3.04
0.76
65.65
* Includes applicable Disaster-Recovery Adjustment made for Fiscal Year 2024 (See Table 1).
** In year two or any succeeding fiscal year in the qualifying seven-year period, the Disaster-Recovery Adjustment is 25 percent of the percentage point decrease between the regular FMAP for such fiscal year and the FMAP from the preceding fiscal year, including any disaster-recovery
adjustments.
[FR Doc. 2024–27938 Filed 11–27–24; 8:45 am]
BILLING CODE 4150–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that an in-person meeting is scheduled
to be held for the Presidential Advisory
Council on Combating AntibioticResistant Bacteria (PACCARB); the main
focus of the meeting is to solicit
feedback from invited presenters and
members of the public on the 2025–
2020 National Action Plan on
Combating Antibiotic Resistant Bacteria.
The meeting will be open to the public
as well as streamed live on hhs.gov/live.
A pre-registered public comment and
innovation spotlight session will be
held during the meeting. Pre-registration
is required for members of the public
who wish to present their comments or
innovations live during the meeting.
DATES: The meeting is scheduled to be
held on January 28–29, 2025, from 9
a.m. to 5 p.m. ET (times are tentative
and subject to change). The confirmed
times and agenda items for the meeting
will be posted on the website for the
PACCARB at https://www.hhs.gov/
paccarb when this information becomes
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
available. Pre-registration for attending
the meeting is strongly suggested and
should be completed no later than
January 24, 2025.
ADDRESSES: The meeting will be held inperson at The Ritz-Carlton, Pentagon
City, 1250 S. Hayes St., Arlington, VA
22202. The meeting will also be live
streamed and can be accessed through a
live webcast on the day of the meeting.
Additional instructions regarding
attending this meeting virtually will be
posted at least one week prior to the
meeting at: https://www.hhs.gov/
paccarb.
Individuals who wish to send in their
written public comment should submit
it via email to CARB@hhs.gov.
Registration information is available on
the website https://www.hhs.gov/
paccarb and must be completed by
January 24, 2025, to attend the January
28–29, 2025, public meeting or by
January 21, 2025, to provide public
comment or innovation spotlight at the
meeting. Additional information about
registering for the meeting and
providing public comment can be
obtained at https://www.hhs.gov/
paccarb on the Upcoming Meetings
page.
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202–746–
1512; Email: CARB@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Order 13676, is continued by section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the PACCARB are governed by
the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C. app.), which
sets forth standards for the formation
and use of Federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary of
Health and Human Services (Secretary)
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: the effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
E:\FR\FM\29NON1.SGM
29NON1
khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
States capabilities to combat antibiotic
resistance.
The focus of the January 28–29, 2025,
meeting is to provide input and
information to the Combating
Antibiotic-Resistant Bacteria (CARB)
Federal Task Force as they develop the
next five-year iteration of the CARB
National Action Plan 2025–2030. The
meeting will focus on innovative and
emerging topics in antimicrobial
resistance (AMR), as well as insights
from international CARB counterparts.
The topics presented at the public
meeting include: an overview of other
partner country CARB National Action
Plans; methods to measure global
awareness of AMR; the impact of AMR
and food security; AMR as a national
security threat; a reflection on the
United Nations General Assembly
Political Declaration by Federal
agencies; the economics of AMR;
innovations to combat AMR; among
other topics.
Members of the public are invited to
provide comment, especially on the
2025–2030 CARB National Action Plan,
during an extended public comment
session, in-person during the meeting by
pre-registering online at https://
www.hhs.gov/paccarb; pre-registration
is required for participation in this
session. Additionally, companies or
organizations working to combat
antimicrobial resistance my share their
innovation during the January meeting
by pre-registering to speak during the
meeting’s Innovation Spotlight. Preregistration online at https://
www.hhs.gov/paccarb is required for
participation in this session, and limited
spots are available. The meeting agenda
will be posted on the PACCARB website
at https://www.hhs.gov/paccarb when it
has been finalized. All agenda items are
tentative and subject to change.
Instructions regarding attending the
meeting virtually will be posted at least
one week prior to the meeting at:
https://www.hhs.gov/paccarb. For those
unable to attend in person, but who
wish to provide input into the next
iteration of the CARB National Action
Plan 2025–2030, may provide written
public comments that can be emailed to
CARB@hhs.gov by midnight January 21,
2025. All public comments received via
email prior to January 21, 2025, will be
provided to the PACCARB and
Interagency CARB Task Force members.
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
Dated: November 18, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
[FR Doc. 2024–28075 Filed 11–27–24; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
General Compliance Program
Guidance; Industry Segment-Specific
Compliance Program Guidance for
Skilled Nursing Facilities and Nursing
Facilities; Resources for Industry;
Availability
Office of Inspector General
(OIG), Department of Health and Human
Services (HHS).
ACTION: Notice of availability.
AGENCY:
OIG is announcing the
availability of the following resources
for industry: General Compliance
Program Guidance (GCPG) and Industry
Segment-Specific Compliance Program
Guidance for Skilled Nursing Facilities
and Nursing Facilities (Nursing Facility
ICPG).
ADDRESSES: You may submit written
electronic comments on these resources
at any time by emailing Compliance@
oig.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
GCPG: Contact Amanda Copsey, (202)
577–6982, or Laura Ellis, (202) 834–
1665.
Nursing Facility ICPG: Contact Laura
Morgan, (240) 930–2425, or Felicia
Heimer, (202) 770–7017.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
On April 24, 2023, OIG announced 1
its plans to improve and update existing
OIG Compliance Program Guidance
documents (CPGs) and to deliver new
CPGs specific to segments of the health
care industry and entities involved in
the health care industry that have
emerged in recent years.
Our April 2023 announcement
explained, in part, that:
• OIG developed CPGs as voluntary,
nonbinding guidance documents to
encourage the development and use of
internal controls to monitor adherence
to applicable statutes, regulations, and
program requirements.
• OIG will no longer publish updated
or new CPGs in the Federal Register.
1 Modernization of Compliance Program
Guidance Documents, 88 FR 25000 (Apr. 25, 2023).
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
94749
All current, updated, and new CPGs
will be available on our website.2
• OIG has developed a new format for
CPGs:
Æ First, the GCPG pertains to all
individuals and entities involved in the
health care industry.
Æ Second, industry segment-specific
CPGs (ICPGs) pertain to different types
of providers, suppliers, and other
participants in health care industry
subsectors or ancillary industry sectors
relating to Federal health care programs.
Please reference the April 2023
announcement for additional details.
II. Notice of Availability
Through this Notice of Availability,
OIG is announcing the availability of the
following documents:
• GCPG: This document was
published on OIG’s website on
November 6, 2023. OIG notified the
public of the publication of the GCPG
using our public listserv 3 and other
communications platforms. The GCPG
may be viewed and downloaded at
https://oig.hhs.gov/compliance/generalcompliance-program-guidance/ and
https://oig.hhs.gov/documents/
compliance-guidance/1135/HHS-OIGGCPG-2023.pdf.
• Nursing Facility ICPG: This
document was published on OIG’s
website on November 20, 2024. OIG is
notifying the public of the publication
of the Nursing Facility ICPG using our
public listserv and other
communications platforms. The Nursing
Facility ICPG may be viewed and
downloaded at https://oig.hhs.gov/
compliance/nursing-facility-icpg and
https://oig.hhs.gov/documents/
compliance/10038/nursing-facilityicpg.pdf.
These resources are not one-size-fitsall, comprehensive, or all-inclusive of
compliance and quality considerations
or risks. They are not binding on any
individual or entity. Of note, OIG uses
the word ‘‘should’’ in the GCPG and
Nursing Facility ICPG to present
voluntary, nonbinding guidance. This
means that the documents do not create
any new obligations or standards for any
individual or entity.
OIG may update the GCPG and
Nursing Facility ICPG periodically to
address newly identified risk areas and
compliance and quality measures,
ensure timely and meaningful OIG
resources, and respond to stakeholder
feedback. In addition, OIG anticipates
2 All CPGs issued to date are currently available
on the Compliance Guidance page of our website
at https://oig.hhs.gov/compliance/complianceguidance/ (last visited Nov. 15, 2024).
3 To join OIG’s listserv, visit https://
cloud.connect.hhs.gov/OIG/.
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94748-94749]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that an in-person meeting is scheduled to be held for the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB);
the main focus of the meeting is to solicit feedback from invited
presenters and members of the public on the 2025-2020 National Action
Plan on Combating Antibiotic Resistant Bacteria. The meeting will be
open to the public as well as streamed live on hhs.gov/live. A pre-
registered public comment and innovation spotlight session will be held
during the meeting. Pre-registration is required for members of the
public who wish to present their comments or innovations live during
the meeting.
DATES: The meeting is scheduled to be held on January 28-29, 2025, from
9 a.m. to 5 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the PACCARB at https://www.hhs.gov/paccarb when this
information becomes available. Pre-registration for attending the
meeting is strongly suggested and should be completed no later than
January 24, 2025.
ADDRESSES: The meeting will be held in-person at The Ritz-Carlton,
Pentagon City, 1250 S. Hayes St., Arlington, VA 22202. The meeting will
also be live streamed and can be accessed through a live webcast on the
day of the meeting. Additional instructions regarding attending this
meeting virtually will be posted at least one week prior to the meeting
at: https://www.hhs.gov/paccarb.
Individuals who wish to send in their written public comment should
submit it via email to [email protected]. Registration information is
available on the website https://www.hhs.gov/paccarb and must be
completed by January 24, 2025, to attend the January 28-29, 2025,
public meeting or by January 21, 2025, to provide public comment or
innovation spotlight at the meeting. Additional information about
registering for the meeting and providing public comment can be
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are
governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth
standards for the formation and use of Federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary of Health and Human Services
(Secretary) regarding programs and policies intended to reduce or
combat antibiotic-resistant bacteria that may present a public health
threat and improve capabilities to prevent, diagnose, mitigate, or
treat such resistance. The PACCARB shall function solely for advisory
purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
[[Page 94749]]
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The focus of the January 28-29, 2025, meeting is to provide input
and information to the Combating Antibiotic-Resistant Bacteria (CARB)
Federal Task Force as they develop the next five-year iteration of the
CARB National Action Plan 2025-2030. The meeting will focus on
innovative and emerging topics in antimicrobial resistance (AMR), as
well as insights from international CARB counterparts. The topics
presented at the public meeting include: an overview of other partner
country CARB National Action Plans; methods to measure global awareness
of AMR; the impact of AMR and food security; AMR as a national security
threat; a reflection on the United Nations General Assembly Political
Declaration by Federal agencies; the economics of AMR; innovations to
combat AMR; among other topics.
Members of the public are invited to provide comment, especially on
the 2025-2030 CARB National Action Plan, during an extended public
comment session, in-person during the meeting by pre-registering online
at https://www.hhs.gov/paccarb; pre-registration is required for
participation in this session. Additionally, companies or organizations
working to combat antimicrobial resistance my share their innovation
during the January meeting by pre-registering to speak during the
meeting's Innovation Spotlight. Pre-registration online at https://www.hhs.gov/paccarb is required for participation in this session, and
limited spots are available. The meeting agenda will be posted on the
PACCARB website at https://www.hhs.gov/paccarb when it has been
finalized. All agenda items are tentative and subject to change.
Instructions regarding attending the meeting virtually will be posted
at least one week prior to the meeting at: https://www.hhs.gov/paccarb.
For those unable to attend in person, but who wish to provide input
into the next iteration of the CARB National Action Plan 2025-2030, may
provide written public comments that can be emailed to [email protected] by
midnight January 21, 2025. All public comments received via email prior
to January 21, 2025, will be provided to the PACCARB and Interagency
CARB Task Force members.
Dated: November 18, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2024-28075 Filed 11-27-24; 8:45 am]
BILLING CODE 4150-44-P
